tiprankstipranks
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
Holding LIXT?
Track your performance easily

Lixte Biotechnology Holdings (LIXT) Financial Statements

67 Followers

Lixte Biotechnology Holdings Financial Overview

Lixte Biotechnology Holdings's market cap is currently ―. The company's EPS TTM is $-1.778; its P/E ratio is -0.84; Lixte Biotechnology Holdings is scheduled to report earnings on April 27, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -984.98K$ -1.01M$ 969.62K$ -1.02M$ -1.67M
EBITDA$ -984.98K$ -1.01M$ 969.62K$ -1.02M$ -1.67M
Net Income Common Stockholders$ -986.03K$ -1.01M$ -971.32K$ -1.03M$ -1.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.64M$ 2.60M$ 3.41M$ 4.20M$ 2.91M
Total Assets$ 1.70M$ 2.67M$ 3.59M$ 4.31M$ 3.10M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.64M$ -2.60M$ -3.41M$ -4.20M$ -2.91M
Total Liabilities$ 328.96K$ 421.46K$ 246.69K$ 313.86K$ 402.61K
Stockholders Equity$ 1.37M$ 2.25M$ 3.13M$ 3.99M$ 2.69M
Cash Flow-
Free Cash Flow$ -957.60K$ -819.04K$ -789.23K$ -902.12K$ -1.18M
Operating Cash Flow$ -957.60K$ -819.04K$ -789.23K$ -902.12K$ -1.18M
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

Lixte Biotechnology Holdings Debt to Assets

Lixte Biotechnology Holdings Cash Flow

Lixte Biotechnology Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis